We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Diagnostic Tools Unveiled at EuroMedLab Exhibition

By LabMedica International staff writers
Posted on 27 Jun 2017
A major international manufacturer of automated diagnostic instruments and point-of-care diagnostic products has changed its name, a change that was highlighted at the IFCC EuroMedLab Athens June 12-14, 2017, exhibition.

Siemens Healthineers (Erlangen, Germany), which is the separately managed healthcare business of Siemens AG (Munich, Germany) presented its latest Atellica Portfolio offerings at the Athens exhibition.

The Portfolio included: Atellica Solution (flexible, scalable, automation-ready immunoassay, and clinical chemistry analyzers), Atellica 1500 Automated Urinalysis System (fully digital, automated urinalysis system), Atellica NEPH 630 System (mid-volume, dedicated nephelometric system that simplifies specialty protein testing), Atellica COAG 360 System (fully automated high-volume coagulation system that unifies five testing methodologies), Atellica MDX 160 System (flexible, automated molecular system with maximum productivity for multiple sample types), and Atellica PM 1.0 Software (process management software to optimize lab operations through data analytics and visualization).

In addition, the Athens presentation featured the RAPIDComm Data Management System, which enables centrally managed point-of-care testing programs through a single customizable interface.

“The 2017 product display from Siemens Healthineers represents our focus on engineering success and pioneering healthcare,” said Franz Walt, president of laboratory diagnostics at Siemens Healthineers. More...
“The Atellica portfolio epitomizes engineering excellence - with revolutionary innovations designed to give lab professionals control and simplicity so they can spend less time on operations and more time on driving better outcomes.”

“The informatics solutions from Siemens Healthineers are designed to address connectivity challenges to help position point-of-care testing programs for success,” said Peter Koerte, president of point-of-care diagnostics at Siemens Healthineers. “Through open connectivity to more than 150 devices from all leading point-of-care vendors, we deliver secure - yet flexible - connectivity options that increase both choice and performance for greater efficiency.”


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hemodynamic System Monitor
OptoMonitor
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.